189 related articles for article (PubMed ID: 26422284)
1. Bleomycin-associated Lung Toxicity in Childhood Cancer Survivors.
Zorzi AP; Yang CL; Dell S; Nathan PC
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e447-52. PubMed ID: 26422284
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin.
De A; Guryev I; LaRiviere A; Kato R; Wee CP; Mascarenhas L; Keens TG; Venkatramani R
Pediatr Blood Cancer; 2014 Sep; 61(9):1679-84. PubMed ID: 24789770
[TBL] [Abstract][Full Text] [Related]
3. The effect of pulmonary function testing on bleomycin dosing in germ cell tumours.
Roncolato FT; Chatfield M; Houghton B; Toner G; Stockler M; Thomson D; Friedlander M; Gurney H; Rosenthal M; Grimison P;
Intern Med J; 2016 Aug; 46(8):893-8. PubMed ID: 27305276
[TBL] [Abstract][Full Text] [Related]
4. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
[TBL] [Abstract][Full Text] [Related]
5. Monitoring pulmonary health in Swiss childhood cancer survivors.
Kasteler R; Kam LMH; Weiss A; Waespe N; Sommer G; Singer F; von der Weid NX; Ansari M; Kuehni CE;
Pediatr Blood Cancer; 2018 Oct; 65(10):e27255. PubMed ID: 29905401
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer.
Mulder RL; Thönissen NM; van der Pal HJ; Bresser P; Hanselaar W; Koning CC; Oldenburger F; Heij HA; Caron HN; Kremer LC
Thorax; 2011 Dec; 66(12):1065-71. PubMed ID: 21803931
[TBL] [Abstract][Full Text] [Related]
7. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman.
Ahmed BM; Al-Zakwani IS
J Oncol Pharm Pract; 2013 Mar; 19(1):3-7. PubMed ID: 22504168
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary function in children treated for rhabdomyosarcoma.
Kaplan E; Sklar C; Wilmott R; Michaels S; Ghavimi F
Med Pediatr Oncol; 1996 Aug; 27(2):79-84. PubMed ID: 8649324
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary complications in survivors of childhood hematological malignancies: single-center experience.
Tantawy AA; Elbarbary N; Ahmed A; Mohamed NA; Ezz-Elarab S
Pediatr Hematol Oncol; 2011 Aug; 28(5):403-17. PubMed ID: 21728717
[TBL] [Abstract][Full Text] [Related]
10. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
[TBL] [Abstract][Full Text] [Related]
11. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
[TBL] [Abstract][Full Text] [Related]
12. [Bleomycin and pulmonary function changes in children with malignant lymphomas].
Kuijten RR; Voûte PA; van Nierop JC; van Leeuwen EF; Griffioen RW; Wagner-Soeters RE
Ned Tijdschr Geneeskd; 1991 Feb; 135(6):225-8. PubMed ID: 1706483
[TBL] [Abstract][Full Text] [Related]
13. Abnormal pulmonary function in adults with sickle cell anemia.
Klings ES; Wyszynski DF; Nolan VG; Steinberg MH
Am J Respir Crit Care Med; 2006 Jun; 173(11):1264-9. PubMed ID: 16556694
[TBL] [Abstract][Full Text] [Related]
14. Low incidence of long-term respiratory impairment in Hodgkin lymphoma survivors.
Avivi I; Hardak E; Shaham B; Igla M; Rowe JM; Dann EJ
Ann Hematol; 2012 Feb; 91(2):215-21. PubMed ID: 21603918
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary function assessment during bleomycin therapy.
Lampert-Benignus E; Eichler-Reiss F; Meunier-Carius J; Keiling R
Biomed Pharmacother; 1985; 39(2):87-93. PubMed ID: 2410052
[TBL] [Abstract][Full Text] [Related]
16. Carbon monoxide diffusing capacity: a reliable indicator of bleomycin-induced pulmonary toxicity.
Sørensen PG; Rossing N; Rørth M
Eur J Respir Dis; 1985 May; 66(5):333-40. PubMed ID: 2410287
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin-related lung damage: CT evidence.
Bellamy EA; Husband JE; Blaquiere RM; Law MR
Radiology; 1985 Jul; 156(1):155-8. PubMed ID: 2408293
[TBL] [Abstract][Full Text] [Related]
18. Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients.
Comis RL; Kuppinger MS; Ginsberg SJ; Crooke ST; Gilbert R; Auchincloss JH; Prestayko AW
Cancer Res; 1979 Dec; 39(12):5076-80. PubMed ID: 91430
[TBL] [Abstract][Full Text] [Related]
19. Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma.
Oguz A; Tayfun T; Citak EC; Karadeniz C; Tatlicioglu T; Boyunaga O; Bora H
Pediatr Blood Cancer; 2007 Oct; 49(5):699-703. PubMed ID: 17420991
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
